Valute / BDRX
BDRX: Biodexa Pharmaceuticals plc - American Depositary Shares
0.86
USD
0.02
(2.27%)
Il tasso di cambio BDRX ha avuto una variazione del -2.27% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 0.86 e ad un massimo di 0.89.
Segui le dinamiche di Biodexa Pharmaceuticals plc - American Depositary Shares. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BDRX News
- Investing Biodexa advances FAP treatment with phase 3 trial initiation
- Benzinga How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market - Biodexa Pharmaceuticals (NASDAQ:BDRX), Palvella Therapeutics (NASDAQ:PVLA)
- TipRanks Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested - TipRanks.com
- Investing Biodexa Pharmaceuticals to implement 1:10 ADR ratio change
- Investing Biodexa files European clinical trial application for FAP treatment
- Investing Results of Annual General Meeting
- Investing Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
- Investing Biodexa enrolls first patient in type 1 diabetes drug trial
- Benzinga Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
- Investing Biodexa Pharmaceuticals changes share nominal value
- Investing Biodexa shareholders approve all resolutions at general meeting
- Investing Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes
- Investing Shareholder Update
- Benzinga Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Biodexa Pharmaceuticals (NASDAQ:BDRX)
- Investing Biodexa secures additional $3M for cancer drug trial
- Investing Biodexa Pharmaceuticals adjusts warrant exercise price
Intervallo Giornaliero
0.86
0.89
Intervallo Annuale
0.23
10.89
- Chiusura Precedente
- 0.88
- Apertura
- 0.88
- Bid
- 0.86
- Ask
- 1.16
- Minimo
- 0.86
- Massimo
- 0.89
- Volume
- 157
- Variazione giornaliera
- -2.27%
- Variazione Mensile
- 0.00%
- Variazione Semestrale
- -80.09%
- Variazione Annuale
- 21.13%
30 luglio, mercoledì
12:15
USD
- Agire
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Agire
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Agire
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Agire
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Agire
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Agire
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Agire
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Agire
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Agire
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Agire
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Agire
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Agire
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Agire
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Agire
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Agire
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Agire
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Agire
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Agire
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Agire
- Fcst
- Prev
- 0.087 M
14:30
USD
- Agire
- Fcst
- Prev
- 1.6%
18:00
USD
- Agire
- Fcst
- Prev
18:00
USD
- Agire
- Fcst
- Prev
- 4.50%
18:30
USD
- Agire
- Fcst
- Prev